ARTICLE
Auteur(s) : T Günther
Charité–Universitätsmedizin Berlin, Campus Benjamin Franklin,
Institut für Molekularbiologie und Biochemie, Arnimallee 22, 14195
Berlin, Germany
Compartmentation of intracellular Mg2+
Only 1% of total body Mg2+ (about 1 mole) is localized
in the extracellular fluid. Of the remainder, 50-60% are adsorbed
to hydroxyapatite crystals of bone and 40-50% are localized
intracellularly. Hence, Mg2+ is an intracellular cation.
Total intracellular Mg2+ in various cell types and
tissues amounts to 3-9 mmol/kg wet weight [1]. Due to
Mg2+ binding to DNA, nucleus-containing cells have a
higher Mg2+ content than unnucleated cells. Rapidly
growing cells have a higher Mg2+ content than slowly
growing cells due to their higher content of ribosomes and thus
Mg2+ bound to rRNA.
In context with these facts, intracellular Mg2+ is
compartmentalized. The percentage of Mg2+ localized in
nuclei, mitochondria, microsomes (ribosomes) and cytosol is shown
in table 1( Table 1 ). The
differences found by various investigators are probably caused by a
different intensity in tissue homogenisation. For a detailed
discussion, see [1, 2]. These values are based on the total
Mg2+ contents and include bound Mg2+ and free
Mg2+. [Mg2+]i in a cellular
compartment depends on total Mg2+, on the concentration
of Mg2+-binding substances, on their Mg2+
affinity, and on the Mg2+ transport activity of the
membranes.
Table 1 Subcellular distribution of Mg2+ in
rat liver. Values provided by 3 different investigators in % of
total Mg2+ were taken from [1, 2].
|
1
|
2
|
3
|
|
Nuclei
|
13.4
|
16.3
|
47.8
|
|
Mitochondria
|
21.8
|
23.2
|
17.4
|
|
Microsomes
|
48.0
|
45.2
|
13.7
|
|
Cytosol
|
12.8
|
14.1
|
19.2
|
Determination of [Mg2+]i
Methods to measure [Mg2+]i are based on
Mg2+-binding fluorescent indicators, e.g. furaptra, also
called mag-fura-2, 31P NMR and Mg2+-sensitive
microelectrodes. In some cases null-point and enzymatic methods
were used. For a review see [3-5].
Furaptra
In this method, [Mg2+]i is determined
according to:
Rmin and Rmax are the excitation wave
length ratios at 335/370 nm for uncomplexed (excess EDTA) and
Mg2+-saturated furaptra respectively. Sf and
Sb are the fluorescence intensities measured at the 370
nm excitation wave length for furaptra with excess EDTA and excess
Mg2+ respectively. R is the excitation ratio at 335/370
nm of the sample to be measured. For KD of the Mg
furaptra complex, usually a value of 1.5 mM was used. For
uncertainty of KD see below.
31P NMR
Many investigators have determined [Mg2+]i
according to:where ø is usually calculated from the chemical shift
differences of the α and β phosphorus peaks of ATP due to binding
of Mg2+. Some investigators also used other formulae to
determine [Mg2+]i from 31P NMR
measurements. For details see [6].
KDMgATP represents the dissociation
constant of the MgATP complex. KDMgATP values
have been measured for more than 50 years. A selection of these
values is listed in table 2A( Table
2 ). More values for KDMgATP are
shown in table 3( Table 3 ). Also,
when measured by various investigators under identical conditions
of temperature, pH and ionic strength, the values measured for
KD of MgATP show great variability.
Table 2 A) Various values of the dissociation
constant (KD) of the MgATP complex as published by
various authors. Values for log KA (association
constant) from [12] were calculated as KD for comparison
with the values provided by other authors.B) Dissociation
constant of MgATP (KD) as a function of pH and
temperature according to [14, 20].C) Dissociation constant
of MgATP (KD) as a function of ionic strength at 25 °C
and pH 7.2 according to [14].
|
A)
|
|
T (°C)
|
pH
|
Ionic strength (M)
|
KD (μM)
|
Ref.
|
|
20
|
|
0.1 KCl
|
144
|
[12]
|
|
25
|
|
0.1 KCl
|
91.2
|
[12]
|
|
25
|
|
0.1 KCl
|
56.2
|
[12]
|
|
25
|
|
0.1 TEABr
|
42.6
|
[12]
|
|
30
|
|
0.1 TEABr
|
9.6
|
[12]
|
|
25
|
7.0
|
0.1 TEABr
|
37.4
|
[13]
|
|
25
|
7.2
|
0.14 KCl, 0.014 NaCl
|
127.5
|
[14]
|
|
25
|
7.2
|
0.14 KCl, 0.01 NaCl
|
45
|
[15]
|
|
37
|
7.2
|
0.13 KCl, 0.02 NaCl
|
83.3
|
[16]
|
|
37
|
7.2
|
0.14 KCl, 0.014 NaCl
|
87.4
|
[14]
|
|
37
|
7.2
|
0.15 KCl
|
38
|
[17]
|
|
37
|
7.2
|
0.15 KCl
|
46
|
[18]
|
|
B)
|
|
KD (μM)
|
|
pH
|
25° C
|
37° C
|
|
6.7
|
157.0
|
106.6
|
|
7.2
|
127.5
|
87.4
|
|
7.7
|
101.0
|
78.1
|
|
C)
|
|
Ionic strength (M)
|
KD (μM)
|
|
0.087
|
61.9
|
|
0.156
|
243.0
|
|
0.300
|
127.5
|
Table 3 Concentration of intracellular free
Mg2+ ([Mg2+]i) in various cell
types and tissues as measured with various methods. The used
dissociation constants of Mgfuraptra and MgATP as well as the used
Mg2+ sensor in the Mg2+ electrodes were
listed.
|
Cells / Tissue
|
Method
|
KD
|
[Mg2+]i (mM)
|
Ref.
|
|
Frog muscle fibers
|
Furaptra
|
4.6 mM
|
1.7
|
[21]
|
|
Chicken cardiomyocytes
|
Furaptra
|
1.5 mM
|
0.48
|
[22]
|
|
Rat hepatocytes
|
Furaptra
|
1.5 mM
|
0.59
|
[23]
|
|
VSMC
|
Furaptra
|
1.5 mM
|
0.48
|
[24]
|
|
Guinea pig tenia cecum
|
Furaptra
|
5.4 mM
|
0.98
|
[25]
|
|
A7r5 cells
|
Furaptra
|
5.4 mM
|
0.74
|
[25]
|
|
A7r5 cells
|
Furaptra
|
1.5 mM
|
0.31
|
[26]
|
|
Rat cardiomyocytes
|
Furaptra
|
5.4 mM
|
1.13
|
[25]
|
|
Rat cardiomyocytes
|
Furaptra
|
5.3 mM
|
0.91
|
[27]
|
|
BC3H-1 cells (fibroblasts)
|
Furaptra
|
1.58 mM
|
0.54
|
[28]
|
|
Pancreatic acinar cells
|
Furaptra
|
1.5 mM
|
1.39
|
[29]
|
|
Human lymphocytes
|
Furaptra
|
2.1 mM
|
0.24
|
[30]
|
|
Mouse skeletal muscle
|
Mag-indo-1
|
5.1 mM
|
1.53
|
[31]
|
|
Rat erythrocytes
|
31P NMR
|
44.3 μM
|
0.193
|
[11]
|
|
Human erythrocytes
|
31P NMR
|
38 μM
|
0.223
|
[32]
|
|
Human erythrocytes
|
31P NMR
|
50 μM
|
0.225
|
[33]
|
|
Human erythrocytes
|
Null-point
|
|
0.4
|
[34]
|
|
Rat erythrocytes
|
Null-point
|
|
0.38
|
[35]
|
|
Rat brain
|
31P NMR
|
44.3 μM
|
0.47
|
[11]
|
|
Rat brain
|
31P NMR
|
90 μM
|
0.56
|
[36]
|
|
Guinea pig brain
|
31P NMR
|
86 μM
|
0.33
|
[37]
|
|
Human brain
|
31P NMR
|
20.6 μM
|
0.32
|
[38]
|
|
Human brain
|
31P NMR
|
44.3 μM
|
0.35
|
[11]
|
|
Rat liver
|
31P NMR
|
86 μM
|
0.7
|
[39]
|
|
Rat liver
|
31P NMR
|
50 μM
|
0.8
|
[40]
|
|
Rabbit uterus
|
31P NMR
|
29 μM
|
0.4
|
[41]
|
|
Human skeletal muscle
|
31P NMR
|
50 μM
|
0.557
|
[42]
|
|
Human skeletal muscle
|
31P NMR
|
44.3 μM
|
0.47
|
[11]
|
|
Guinea pig heart
|
31P NMR
|
28.7 μM
|
2.5
|
[43]
|
|
Frog skeletal muscle
|
31P NMR
|
45 μM
|
0.6
|
[44]
|
|
Guinea pig tenia cecum
|
31P NMR
|
41 μM
|
0.33
|
[45]
|
|
Ascites tumor cells
|
31P NMR
|
60 μM
|
0.44
|
[46]
|
|
Human platelets
|
31P NMR
|
38 μM
|
0.23
|
[47]
|
|
Human platelets
|
Null-point
|
|
0.3
|
[47]
|
|
Mouse lymphocytes
|
Null-point
|
|
0.9
|
[48]
|
|
Mouse lymphocytes
|
Mg2+ electrode ETH1117
|
|
1.35
|
[48]
|
|
Frog skeletal muscle
|
Mg2+ microelectr. ETH1117
|
|
3.8
|
[49]
|
|
Frog skeletal muscle
|
Mg2+ microelectr. ETH1117
|
|
3.3
|
[50]
|
|
Frog skeletal muscle
|
Mg2+ microelectr. ETH1117
|
|
1.3
|
[51]
|
|
Rat skeletal muscle
|
Mg2+ microelectr. ETH1117
|
|
0.47
|
[52]
|
|
Guinea pig heart
|
Mg2+ microelectr. ETH5214
|
|
0.72
|
[53]
|
|
Ferret myocard
|
Mg2+ microelectr. ETH5214
|
|
0.85
|
[54]
|
|
Ferret myocard
|
Mg2+ microelectr. ETH1117
|
|
3.0
|
[50]
|
|
Pancreatic acinar cells
|
Mg2+ microelectr. ETH5214
|
|
0.58
|
[55]
|
|
Snail neurones
|
Mg2+ microelectr. ETH1117
|
|
0.66
|
[56]
|
Mg2+-sensitive microelectrodes
Mg2+-sensitive microelectrodes are based on the neutral
ionophores ETH 1117 or on the more specific derivative ETH 5214
with less K+ interference. Values for
[Mg2+]i are obtained by comparing the
electrode potential measured in the cytosol minus membrane
potential with the electrode potential of a calibration solution
which, because of ion interferences, should be identical to the
ionic composition of the cytosol.
[Mg2+]i in cell organelles and
cytosol
[Mg2+]i in sarcoplasmic (endoplasmic)
reticulum as measured by furaptra amounted to 1.0 mM [7].
[Mg2+]i in mitochondria is about the same
as [Mg2+]i in the cytosol [8]. Values of 0.67
mM [9], 0.5 mM and 0.8 - 1.5 mM and 0.82 mM, determined by furaptra
in isolated beef heart mitochondria, have been reported [10]. Since
there is a membrane potential of 200 mV inside negative across the
mitochondrial membrane, there should be an outside directed
Mg2+ transport mechanism. Mg2+ influx into
mitochondria may be mediated by a protein (Mrs2p) that is inserted
into the inner mitochondrial membrane [11].
Tables 3 and 4( Table 4 ) present a
selection of the values of [Mg2+]i in the
cytosol taken from the enormous number of values reported by
various investigators for different cell types and tissues. More
values for [Mg2+]i measured by various
methods are listed in [14, 68]. As shown in table 3, very
different KDs for Mg furaptra and MgATP were used. The
KDs varied by a factor of up to 4. However, the
variation of [Mg2+]i within the same cell
type is less expressed than was to be expected with respect to the
different KDs e.g. in A7r5 cells, a rat embryonal aortic
muscle derived cell line, or in brain.
When [Mg2+]i was measured in the same cell
type (lymphocytes) by different methods (furaptra, null-point,
Mg2+ electrode), different values (0.15 mM
(table 4), 0.24 mM, 0.9 mM and 1.35 mM (table 3)) were
obtained. In erythrocytes, the null- point method yielded higher
values than 31P NMR (0.4 mM versus 0.2 mM). See also
[8]. Also, the same method used by various investigators yielded
very different values of [Mg2+]i in the same
cell type: in resting platelets 0.266 mM to 0.644 mM, in VSMC 0.31
mM and 0.62 mM (table 4).
With Mg2+ microelectrodes, the first measurements of
[Mg2+]i yielded rather high values [49, 50].
Later measurements yielded values for [Mg2+]i
in the range as measured by other methods.
Table 4 Alteration of [Mg2+]i by
various effectors measured by means of furaptra.
|
Cells
|
Effector
|
[Mg2+]i (mM)
|
Ref.
|
|
|
Resting
|
Stimulated
|
|
|
MDCK cells
|
8-Br-cGMP (0.1 mM)
|
0.552
|
0.682
|
[57]
|
|
MDCK cells
|
8-Br-cAMP (0.1 mM)
|
0.538
|
0.362
|
[57]
|
|
CTAL cells
|
ANP (1 μM)
|
0.525
|
0.592
|
[57]
|
|
CTAL cells
|
8-Br-cGMP (0.1 mM)
|
0.538
|
0.609
|
[57]
|
|
CTAL cells
|
PTH (1 μM)
|
0.540
|
0.497
|
[57]
|
|
CTAL cells
|
Calcitonin (1 μM)
|
0.542
|
0.462
|
[57]
|
|
Human platelets
|
Insulin (200 μU/ml)
|
0.266
|
0.355
|
[58]
|
|
Human platelets
|
Insulin (100 μU/ml)
|
0.614
|
1.270
|
[59]
|
|
Human platelets
|
Thrombin (0.1 U/ml)
|
0.614
|
0.405
|
[59]
|
|
Human platelets
|
Endothelin-1 (1nM)
|
0.58
|
0.59
|
[60]
|
|
Human platelets
|
Angiotensin-II (1 nM)
|
0.58
|
0.40
|
[60]
|
|
Human lymphocytes
|
PHA-L (5 mg/ml)
|
0.15
|
0.25
|
[61]
|
|
Fibroblasts
|
Insulin (100 ng/ml)
|
0.208
|
0.241
|
[62]
|
|
Fibroblasts
|
Bombesin (3 nM)
|
0.208
|
0.304
|
[62]
|
|
Fibroblasts
|
EGF (10 ng/ml)
|
0.208
|
0.244
|
[62]
|
|
Fibroblasts
|
Bombesin (3 nM)
|
0.328
|
0.538
|
[63]
|
|
Fibroblasts
|
Endothelin-1 (0.5 μM)
|
0.328
|
0.538
|
[63]
|
|
Sub.muc.acini
|
Carbachol (10 μM)
|
0.35
|
0.5
|
[64]
|
|
VSMC
|
AVP (1 μM)
|
0.31
|
2.44 (peak)
|
[65]
|
|
VSMC
|
AVP (1 μM)
|
0.31
|
0.42
|
[65]
|
|
VSMC
|
Endothelin-1 (1μM)
|
0.30
|
2.36 (peak)
|
[65]
|
|
VSMC
|
Endothelin-1 (1 μM)
|
0.30
|
0.43
|
[65]
|
|
VSMC
|
AVP (10 nM)
|
0.62
|
0.52
|
[66]
|
|
VSMC
|
Angiotensin-II (10nM)
|
0.62
|
0.8 (peak)
|
[66]
|
|
VSMC
|
Angiotensin-II (10 nM)
|
0.62
|
0.46
|
[66]
|
|
Panc.acinar cells
|
Acetylcholine (10 μM)
|
0.82
|
1.06 (peak)
|
[67]
|
|
Panc.acinar cells
|
Acetylcholine (10 μM)
|
0.82
|
0.61
|
[67]
|
|
Panc.acinar cells
|
Cholecystok. (10 nM)
|
0.82
|
1.01 (peak)
|
[67]
|
|
Panc.acinar cells
|
Cholecystok. (10 nM)
|
0.82
|
0.69
|
[67]
|
|
Panc.acinar cells
|
Cholecystok. (01 nM)
|
0.59
|
0.37
|
[55]
|
Uncertainty of [Mg2+]i measurements
Because of limited specificity in the measurement with
Mg2+-sensitive electrodes, the calibration solution must
be identical with the ionic composition of the cytosol. This can be
done with respect to the cations. It is not possible for the
cytosolic anions. Therefore, the calibration must be done on the
basis of the activity of Mg2+ and not on the basis of
the concentration of Mg2+. However, there is uncertainty
about the activity coefficient of Mg2+. In an isotonic
solution the activity coefficient may amount to 0.3 [69] or 0.55
[70]. The higher value is the more correct one. Besides an estimate
of the activity coefficient according to Debye-Hückel for pure salt
solutions, cytoplasma contains proteins that bind water (10%)
without salt (non-solvent water). This effect and the interaction
of Mg2+ with charges of macromolecules and membranes may
lead to an additional reduction in the activity coefficient [71].
There is another common uncertainty. Also KDMg
furaptra and KDMgATP must be determined
in solutions identical to the ionic composition of the cytosol.
However the solutions used are composed on the basis of chloride
salts, and are thus different from the cytosolic anion composition.
Due to its content of inorganic phosphate and phosphate esters, the
Mg2+ activity coefficient in the cytosol is lower than
in the chloride-containing solutions. Besides this uncertainty, the
values for KDMg furaptra used by different
investigators varied from 1.0-6.8 mM [5, 7, 10]. KD
values estimated in situ yielded higher values (2.1 mM [9], 5.3 mM
[27], 5.4 mM [27] and 6.8 mM [7]) than KDs determined
under in vitro conditions (usually 1.5 mM).
For KDMgATP the situation is still more
complex. 31P NMR measures the binding of Mg2+
to phosphoryl groups of ATP. Mg2+ binding is dependent
on pH because the phosphate group dissociates at a pK value of
about 6.8 [12], and is thus dependent on the intracellular pH. The
degree by which the KD of MgATP is dependent on pH is
shown in table 2B. Besides H+, other cations
compete with Mg2+ for binding to ATP. This encludes a
weak binding of K+ and Na+ to ATP (log
KA = 0.99 and 0.98 M-1[12]). To prevent the
interaction of K+ and Na+ with ATP, 0.1 M
tetraethylammonium salt was taken to adjust ionic strength. The
effect of the ionic strength on the dissociation constant of MgATP
is shown in table 2C.
A more realistic determination of KD of MgATP was
performed using an Mg2+-sensitive electrode and a
background solution containing 140 mM K+ and 14.6 mM
Na+. A value of 87.4 μM was obtained at pH 7.2 and 37° C
[14, 20]. The same value (86 μM) was obtained by means of
31P NMR under approximately in vivo conditions [39].
When the more realistic KD of MgATP was used to
recalculate the values of [Mg2+]i measured by
other investigators, the values for [Mg2+]i
increased to a factor of 2.8 [14]. Values of 0.7 to 1.7 mM were
obtained for 14 determinations of [Mg2+]i in
various tissues [14].
Microheterogeneity of [Mg2+]i in the
cytosol
The above reported values of [Mg2+]i are
average values over total cytosol. Compartmentation of cytosolic
Mg2+ was not considered. However, Mg2+ is not
uniformly distributed within the cytosol. Mg2+ is
enriched at negatively charged phospholipids of cellular and
intracellular membranes and at the surface of negatively charged
macromolecules. For a detailed discussion see [2]. The differently
enriched Mg2+ relates to free Mg2+. There is
experimental evidence for a different distribution of free
Mg2+ within the cytosol.
Furaptra applied in cultured rat aortic smooth muscle cells and
using a KD of 1.5 mM yielded an
[Mg2+]i of 0.2 mM in the peripheral area, 0.6
mM in the perinuclear region and about 0.6 mM in the nuclear region
[72]. A heterogeneous distribution of intracellular free
Mg2+ in rat VSMC was also found by other investigators
[73] using furaptra. Using a KD of 1.45 mM,
[Mg2+]i in the nuclear region was 0.32 mM.
[Mg2+]i in the perinuclear region, which
contains the highest density of intracellular organelles, amounted
to 0.4-1.13 mM and the non- nuclear cytoplasmic area had an
[Mg2+]i of 0.77 mM. The peripheral region
near the plasma membrane had the lowest
[Mg2+]i. By using mag-indo-1, other authors
[74] found a mean [Mg2+]i of 1.4 mM in human
tracheal gland cells. Within a single cell,
[Mg2+]i was uniformly distributed within the
nucleoplasm. Cytosolic [Mg2+]i varied from
0.34 mM to 3 mM in another opposing region in the same cell.
Since positively charged Mg2+ ions are enriched at
negatively charged membranes and macromolecules, it must be
expected that the negatively charged furaptra is rejected by these
structures, resulting in erroneous values of
[Mg2+]i. This may be a reason why a low
[Mg2+]i was measured with furaptra near the
plasma membrane, although Mg2+ should be enriched at the
inner side of the negatively charged plasma membrane.
Taken together, besides the uncertainty in the average values of
[Mg2+]i in the cytosol, there is an unequal
distribution of free Mg2+ in the cytosol by a factor
ranging between 3 and 10. The high [Mg2+]i
cannot be explained by enrichment of free Mg2+ in cell
organelles (e.g. mitochondria, endoplasmic reticulum) because
[Mg2+]i in these cell organelles was about
the same as the average [Mg2+]i in the
cytosol (see above). The mechanism causing the heterogeneous
distribution of intracellular free Mg2+ is not
defined.
Metabolic function of intracellular Mg2+
In view of these facts, it is uncertain to define an absolute and
exact value of [Mg2+]i within a defined space
of the cytosol. Besides compartmentation of free Mg2+ in
the cytosol, cytosolic metabolic pathways such as glycogenolysis
and glycolysis are also compartmentalized [75, 76].
Since Mg2+ is enriched at negatively charged
membranes, an exact knowledge of [Mg2+]i at
the inner surface of cell membranes would be essential to define
the role of intracellular Mg2+ in the regulation of
membrane-bound metabolic pathways and in the modulation of
K+ and Ca2+ channels [77] as well as the role
of intracellular Mg2+ in the feedback inhibition of
Mg2+ influx via TRPM7 in the regulation of
[Mg2+]i[78, 79].
Generally, metabolic pathways are regulated by changing the
activity of the rate-limiting enzymes. Usually these are allosteric
enzymes with a complex regulation by activation and feedback
inhibition by various metabolites, end products of biosynthesis and
by effectors. Moreover, these enzymes can be regulated by
phosphorylation-dephosphorylation. During evolution, the regulation
of metabolic pathways was adapted to the requirements of the cell
with respect to energy supply as well as intermediates and end
products for biosynthesis.
What is the role of intracellular Mg2+ in these
mechanisms? All reactions of Mg2+ with ligands such as
low molecular substances (ATP, etc.), proteins, enzymes, and
nucleic acids obey the law of mass action, yielding a sigmoidal
curve when plotted as a function of pMg. With respect to
Mg2+-dependent enzymes at high
[Mg2+]i, enzymes are usually inhibited by
Mg2+. Activation and inhibition of an enzyme by
Mg2+ as a function of pMg results in a bell-shaped curve
[1]. Activation by Mg2+ occurs at the ascending part of
the bell-shaped curve up to the pMg optimum. Alterations of
[Mg2+]i near or within the range of the pMg
optimum of a Mg2+-dependent rate-limiting enzyme have no
significant effect on the rate of a metabolic pathway.
Since the exact absolute value of [Mg2+]i
in the cytosol is uncertain (see above) and as there are
considerable differences in the values of
[Mg2+]i for the same cell type (tables
3, 4), it is uncertain at which degree of activation (part of
the bell-shaped pMg dependency) the Mg2+-dependent
rate-limiting enzymes are operating.
For some glycolytic enzymes, the pMg optimum is at pMg 3 [80,
81]. However, the Mg2+ affinity and the pMg optimum of
enzymes can change. This effect was shown for isolated glycolytic
enzymes, when their Mg2+ dependency was determined at
various constant Mg2+: ATP or Mg2+ : ADP
ratios [81]. This effect may occur in intact cells. The synthesis
of ATP and the utilization of ATP in the cytosol is
compartmentalized [75, 76]. In organisms, there is an additional
mechanism that can change the affinity of Mg2+ to
enzymes. For example, the addition of glucagon to liver cells
resulted in a dramatic decrease in the KM of adenylyl
cyclase for Mg2+[82].
In all Mg2+-dependent enzymes, which use MgATP as a
substrate, an alteration of [Mg2+]i has only
a minor effect on the enzyme activity because ATP is nearly
saturated with Mg2+ (to about 90%). Moreover, an
alteration of MgATP affects enzyme activity according to
Michaelis-Menten kinetics and depends on the KM of MgATP
and the MgATP concentration. Intracellular Mg2+ is
buffered at a high level [20, 83]. Thus, intracellular
Mg2+ is not suitable for a regulatory function. Its
metabolic function can be tested by artificially changed
[Mg2+]i in experiments with intact cells. In
such experiments it was found that [Mg2+]i
did not play a regulatory role in erythrocyte glycolysis [84].
When cells [85] or isolated mitochondria [86] were drastically
Mg2+-depleted by means of A23187, respiration was
reduced. In these experiments, [Mg2+]i in
mitochondria was not measured. Because of the complex effects under
the experimental conditions, it cannot be decided whether
[Mg2+]i in mitochondria has a regulatory or a
permissive function. [Ca2+]i in mitochondria
was also changed in these experiments and may have affected
respiration. For a discussion of the interaction of H+,
Ca2+, inorganic phosphate, spermine and various
cofactors with Mg2+ in respiration and oxidative
phosphorylation, see [87].
The synthesis of purine and pyrimidine precursors of nucleic
acids depends on Mg2+, and at each step of DNA
replication, RNA transcription and RNA translation Mg2+
is required for enzyme function. Mg2+ is a cofactor in
all these processes. Regulation of enzyme activity through changes
in [Mg2+]i has not been observed [88].
Computer models have shown that Mg2+ does not
regulate cardiac metabolism [89].
A drastic reduction in the cellular Mg2+ content by
means of A23187 yielded a reduction in the biosynthesis of
proteins, DNA and RNA, respiration and glycolysis [85]. Again these
experiments did not prove that intracellular Mg2+ has a
regulatory function. They may indicate a permissive function of
intracellular Mg2+. Alternatively to conclusions about a
permissive role of intracellular free Mg2+, other
authors have suggested a regulatory function of intracellular free
Mg2+[89-92].
Mg2+ content in malignant cells
Rapidly dividing normal cells have higher contents of
Mg2+, K+, Na+ and Cl-
than slowly growing normal cells [93]. In rapidly dividing tumor
cells, the concentrations of intracellular Na+ and
Cl- were elevated, whereas intracellular total
Mg2+ and K+ contents were significantly lower
than in rapidly dividing normal cells. Injection of tumorous mice
with amiloride reduced [Na+]i and cell
proliferation without significantly changing total Mg2+
and K+ content. It was concluded that an early brief
surge in [Ca2+]i is essential in mitogenic
stimulation followed by an increase in [Na+]i
and pHi[93].
When rapidly dividing HL60 cells, a promyelocytic leukemia cell
line, were transformed to neutrophilic-like cells by incubation
with retinoic acid, the total Mg2+ content of the cells
was reduced by 19%. The total Mg2+ content in
mitochondria and cytoplasm (cytoplasm was defined as the region
excluding mitochondria and nuclei) were reduced by 18%, and the
Mg2+ content of nuclei was unchanged [94]. The reduction
of total Mg2+ content in cytoplasm may be caused by a
reduction of ATP by 31% and ADP by 40% [94], and by an increase in
Na+/Mg2+ antiport [95]. An alteration of
Mg2+ bound to ribosomes was not investigated. Total
cytoplasmic Ca2+ content in the transformed cells was
reduced by 40%, and the K+/Na+ ratio in
nuclei was reduced by about 28% [94]. The complex mechanisms by
which the contents of the various ions were changed during the
differentiation process of the cells and their metabolic
significance are not defined.
Action of effectors on [Mg2+]i and
[Ca2+]i
[Mg2+]i in nucleated cells is somewhat
constant. It can be changed significantly by effectors. The
development of furaptra and fura-2 offered the possibility of
rapidly and continuously measuring [Mg2+]i
and [Ca2+]i and their alterations by various
effectors.
When intracellular Mg2+ has a regulatory function,
[Mg2+]i must be changed by effectors at a
reasonable concentration within a reasonable time period and to a
reasonable extent. The alterations of [Mg2+]i
after addition of various effectors are listed in table 4.
Remarkably, different investigators measured different values of
[Mg2+]i in resting platelets and a different
increase of [Mg2+]i by insulin as well as
controversial effects by thrombin in these cells. Thrombin
decreased [Mg2+]i in human platelets from
0.614 mM to 0.405 mM [59], whereas other authors found an increase
in [Mg2+]i in platelets from 0.54 mM to 1.33
mM by thrombin [96].
The increases in [Mg2+]i induced by
various effectors at the concentrations listed amounted maximally
to a factor of 2, corresponding to an alteration in pMg of 0.3. A
small part of the increase in [Mg2+]i by some
effectors may include an increase in [Ca2+]i
because of the unspecificity of furaptra. Due to the uncertainty of
an absolute value of [Mg2+]i, the alterations
in [Mg2+]i must be considered as
relative.
Of the effectors listed in table 4, insulin had no effect
on [Ca2+]i[58, 59]. Insulin may increase
Mg2+ uptake into platelets. In VSMC, vasopressin [65,
66] and endothelin-1 [65] induced rapid peaks of
[Mg2+]i and [Ca2+]i
followed by a decrease in [Mg2+]i and
[Ca2+]i. The peak and sustained values of
[Mg2+]i are listed in table 4. The
reduction in [Mg2+]i may be caused by
Mg2+ efflux via Na+/Mg2+ antiport
[65]. Mg2+- and Ca2+-free medium decreased
the vasopressin-mobilized [Ca2+]i by 60.8%
and prevented the increase in [Mg2+]i[65].
Based on these results, the authors concluded that vasopressin and
endothelin-1 mobilized Mg2+ in VSMC through the action
of the intracellular second messenger Ca2+. However, in
A7r5 cells, a VSMC line, 100 nM vasopressin had no effect on
[Mg2+]i[26].
In fibroblasts, bombesin induced an
[Mg2+]i and [Ca2+]i
peak [62, 63], followed by a sustained decrease in
[Mg2+]i and by oscillations of
[Ca2+]i. Endothelin-1 (0.5μM) had a similar
effect on [Mg2+]i as 3 nM bombesin. There was
a considerable variation in the [Mg2+]i
response to bombesin, endothelin-1 [63] and EGF [97] among
different individual cells of the same cell type.
Some effectors have a cell -specific action, e.g. endothelin-1
had no effect on [Mg2+]i and
[Ca2+]i in platelets [60]. 8-Br-cGMP
increased [Mg2+]i in MDCK cells [57] and had
no effect on [Mg2+]i in platelets [59].
The increase in [Mg2+]i by AVP and
endothelin-1 [65] affected [Ca2+]i and
[Mg2+]i simultaneously and in the same
direction. In VSMC, AVP and endothelin [65] and in pancreatic
acinar cells, acetylcholine and cholecystokinin induced short peaks
of [Mg2+]i followed by a decrease in
[Mg2+]i[67]. In a more detailed study with
pancreatic acinar cells, 100 pM cholecystokinin and 100 μM
acetylcholine decreased [Mg2+]i from 0.58 mM
to 0.47 mM. This may be caused by Mg2+ uptake into the
endoplasmic reticulum [55] or by Mg2+ efflux via
Na+/Mg2+ antiport [65, 67]. Cholecystokinin
(10 pM) induced [Ca2+]i oscillations.
Frequency and amplitude of [Ca2+]i
oscillations were increased when [Mg2+]i was
decreased by preincubation at low extracellular Mg2+
concentration [55]. Thus, intracellular Mg2+ can
modulate Ca2+ signaling.
The reviewed alterations in [Ca2+]i
reflect the general function of Ca2+ as a second
messenger. Ca2+ signaling can occur as a single
transition, as a sustained plateau or as repetitive oscillations.
[Ca2+]i oscillations are known to be involved
in the control of a number of important cell processes, e.g.
regulation of gene transcription, where the efficacy of the control
varies with the amplitude and frequency of the oscillations [98,
99]. The different patterns of intracellular Ca2+ reveal
a mechanism by which a multifunctional second messenger as
Ca2+ can achieve specificity in signal transduction [98,
99].
Ca2+ versus Mg2+ as a second
messenger
From the results it can be concluded that some effectors
(vasopressin, endothelin-1, bombesin, cholecystokinin,
acetylcholine, carbachol) primarily increase
[Ca2+]i which secondarily increase
[Mg2+]i through liberation of intracellular
Mg2+. The mechanism of Mg2+ liberation is not
defined. From other experiments it has been suggested that bound
Mg2+ may be released through acidification and by
displacement of protein-bound Mg2+ by
Ca2+[100, 101]. In experiments with pancreatic acinar
cells, an alteration of pHi had no effect on
cholecystokinin-induced changes of [Mg2+]i.
The changes in [Mg2+]i were related to the
release and reuptake of Mg2+ by the endoplasmatic
reticulum [55]. Competition of Ca2+ with protein-bound
Mg2+ may be the probable mechanism. The function of the
effector-induced increase in [Mg2+]i may
enhance Mg2+-dependent reactions to support the
effector-induced mechanisms in the target cells.
The effector-induced alterations of
[Mg2+]i were discussed as evidence that
intracellular Mg2+ is a second messenger [94]. It merely
indicates that intracellular Mg2+ can affect the action
of Ca2+ as a second messenger. Additional evidence that
intracellular Ca2+ but not Mg2+ is the second
messenger was obtained with human lymphocytes stimulated by Con A.
Con A increased [Ca 2+]i and
[Mg2+]i. However,
[Mg2+]i was only elevated in cells with a
high [Ca2+]i[102]. This result indicates that
a sufficient increase in [Ca2+]i is necessary
to induce the increase in [Mg2+]i.
In the complex interactions between intracellular
Mg2+ and Ca2+, [Mg2+]i
has a level at which Ca2+ release is almost maximally
inhibited, and Ca2+ storage is almost maximally
activated by intracellular Mg2+. Thus
[Mg2+]i provides a minimal
[Ca2+]i, so that effectors can induce
pronounced changes in [Ca2+]i[103].
These results are in agreement with the physico-chemical
properties of Ca2+.
Because of the larger diameter of Ca2+ compared with
Mg2+, in multidentate chelates with proteins there is
less ligand-ligand repulsion by the negatively charged chelating
groups. This yields 1000 times lower dissociation constants of
Ca2+ with Ca2+-binding proteins compared with
Mg2+ and to 1000 times lower
[Ca2+]i compared with
[Mg2+]i. Thus Ca2+ was favored
against Mg2+ as a second messenger during evolution. For
details see [99, 104].
Conclusion
Intracellular Mg2+ is buffered by reversibly binding to
ligands such as nucleotides, nucleic acids, proteins, phospholipids
and negatively charged low molecular substances. The exact average
value of [Mg2+]i is uncertain due to
methodical difficulties and higher than usually reported.
Intracellular free Mg2+ and metabolic pathways are
compartmentalized. The Mg2+ affinity and pMg optimum of
enzymes can be changed by altering pH,
[Ca2+]i, substrates, end products, effectors
and hormones. Therefore, the exact quantitative role of
intracellular Mg2+ under the conditions of an intact
cell or tissue cannot be defined. The increase in
[Mg2+]i in various cell types by effectors is
small. Various effectors increase [Ca2+]i and
[Mg2+]i. The alterations in
[Ca2+]i are more expressed than the
alterations in [Mg2+]i. The evidences favor
intracellular Ca2+ as a second messenger. The
simultaneous increase in [Mg2+]i may activate
Mg2+-dependent reactions to support effector-induced
mechanisms in target cells [19].
References
1 Ebel H, Günther T. Magnesium metabolism: A. review. J
Clin Chem Clin Biochem 1980; 18: 257-70.
2 Günther T. Functional compartmentation of intracellular
magnesium. In: Sigel H, Sigel A, eds. Metal ions in
biological systems, Vol. 26. New York, Basel: Marcel Dekker Inc,
1990: 193-213.
3 Mota De Freitas D, Dorus E. Techniques for measuring
magnesium in tissues from hypertensive, psychiatric, and
neurological patients. In: Birch NJ, ed. Magnesium and the
cell. London, Boston, San Diego, New York, Sydney, Tokyo: Academic
Press, 1993: 51-79.
4 London RE. Methods for measurement of intracellular
magnesium: NMR and fluorescence. Annu Rev Physiol 1991; 53:
241-58.
5 Murphy E. Measurement of intracellular ionized magnesium.
Miner Electrolyte Metab 1993; 19: 250-8.
6 Konstanczak P, Schäfer A, Sperner J,
Günther T. Calculation of free Mg2+ concentration
from 31P-NMR spectra of ATP. Magnes Bull 2000; 22:
20-5.
7 Sugiyama T, Goldman WF. Measurement of SR free
Ca2+ and Mg2+ in permeabilized smooth muscle
cells with use of furaptra. Am J Physiol 1995; 269: C698-C705.
8 Günther T. Die intrazelluläre Mg-Ionenkonzentration. Z
Naturforsch 1967; 22b: 149-54.
9 Jung DW, Brierley GP. Matrix free Mg2+
and the regulation of mitochondrial volume. Am J Physiol 1999; 277:
C1194-C1201.
10 Jung DW, Brierley GP. Determination of free
Mg2+ in isolated heart mitochondria using fluorescent
probes. Magnes Trace Elem 1991-1992; 10: 151-64.
11 Weghuber J, Dieterich F, Froschauer EM,
Svidovà S, Schweyen RJ. Mutational analysis of functional
domains in Mrs2p, the mitochondrial Mg2+ channel protein
of Saccharomyces cerevisiae. FEBS J 2006; 273: 1198-209.
12 Sillen LG, Martell AE. Stability constants of
metal-ion complexes. London: The Chemical Society Burlington House,
1971.
13 Nanninga LB. The association constant of the complexes
of adenosine triphosphate with magnesium, calcium, strontium and
barium ions. Biochim Biophys Acta 1961; 54: 330-8.
14 Zhang W, Truttmann AC, Lüthi D,
McGuigan JAS. Apparent Mg2+-adenosine 5-
triphosphate dissociation constant measured with Mg2+
macroelectrodes under conditions pertinent to 31P NMR
ionized magnesium determinations. Anal Biochem 1997; 251:
246-50.
15 Gupta RK, Gupta P, Yushok WD, Rose ZB.
Measurement of the dissociation constant of MgATP at physiological
nucleotide levels by a combination of 31P NMR and
optical absorbance spectroscopy. Biochem Biophys Res Commun 1983;
117: 210-5.
16 Berger H, Jänig GR, Gerber G, Ruckpaul H,
Rappoport SM. Interaction of haemoglobin with ions.
Interactions among magnesium, adenosine 5’-triphosphate, 2,3
bisphosphoglycerate, and oxygenated and deoxygenated human
haemoglobin under simulated intracellular conditions. Eur J Biochem
1973; 38: 553-62.
17 Gupta RK, Benovic JL, Rose ZB. The
determination of the free magnesium level in the human red blood
cell by 31P NMR. J Biol Chem 1978; 253: 6172-6.
18 Woods KL, Walmsley D, Heagerty AM,
Turner DL, Lian L-Y. 31P nuclear magnetic
resonance measurement of free erythrocyte magnesium concentration
in man and its relation to blood pressure. Clin Sci 1988; 74:
513-7.
19 Williams GD, Mosher TJ, Smith MB. Simultaneous
determination of intra-cellular magnesium and pH from the three
31P NMR chemical shifts of ATP. Anal Biochem 1993; 214:
458-67.
20 Lüthi D, Günzel D, McGuigan JAS. Mg-ATP
binding: Its modification by spermine, the relevance to cytosolic
Mg2+ buffering, changes in the intra-cellular ionized
Mg2+ concentration and the estimation of Mg2+
by 31P-NMR. Exp Physiol 1999; 84: 231-52.
21 Westerblad H, Allen DG. Myoplasmic Mg2+
concentration in Xenopus muscle fibres at rest, during fatigue and
during metabolic blockade. Exper Pysiol 1992; 77: 733-40.
22 Murphy E, Freudenrich CC, Levy LA,
London RE, Lieberman M. Monitoring cytosolic free
magnesium in cultured chicken heart cells by use of the fluorescent
indicator furaptra. Proc Natl Acad Sci USA 1989; 86: 2981-4.
23 Raju B, Murphy E, Levy LA, Hall RD,
London RE. A fluorescent indicator for measuring cytosolic
free magnesium. J Am Physiol 1989; 256: C540-C548.
24 Altura BM, Zhang A, Cheng TPO, Altura BT.
Cocaine induces rapid loss of intracellular free Mg2+ in
cerebral vascular smooth muscle cells. Eur J Pharmacol 1993; 246:
299-301.
25 Tashiro M, Konishi M. Basal intracellular free
Mg2+ concentration in smooth muscle cells of guinea pig
tenia cecum: intracellular calibration of the fluorescent indicator
furaptra. Biophys J 1997; 73: 3358-70.
26 Schachter M, Gallagher KL, Sever PS.
Measurement of intracellular magnesium in a vascular smooth muscle
cell line using a fluorescent probe. Biochim Biophys Acta 1990;
1035: 378-80.
27 Watanabe M, Konishi M. Intracellular calibration of
the fluorescent Mg2+ indicator furaptra in rat
ventricular myocytes. Pflügers Arch Eur J Physiol 2001; 442:
35-40.
28 Grubbs RD, Walter A. Determination of cytosolic
Mg2+ activity and buffering in BC3H-1 cells
with mag-fura-2. Mol Cell Biochem 1994; 136: 11-22.
29 Lennard R, Singh J. Secretagogue-evoked changes in
intracellular free magnesium concentrations in rat pancreatic
acinar cells. J Physiol 1991; 435: 483-92.
30 Delva P, Pastori C, Degan M, Montesi G,
Lechi A. Catecholamine-induced regulation in vitro and ex vivo
of intralymphocyte ionized magnesium. J Membr Biol 2004; 199:
163-71.
31 Csernoch L, Bernengo JC, Szentesi P,
Jacquemond V. Measurements of intracellular Mg2+
concentration in mouse skeletal muscle fibers with the fluorescent
indicator mag-indo-1. Biophys J 1998; 75: 957-67.
32 Resnick LM, Altura BT, Gupta RK,
Laragh JH, Alderman MH, Altura BM. Intracellular and
extracellular magnesium depletion in type 2 (non-insulin-
dependent) diavetes mellitus. Diabetologia 1993; 36: 767-70.
33 Petersen A, Kristensen SR, Jacobsen JP,
Horder M. 31P-NMR measurements of ATP, ADP,
2,3-diphosphoglycerate and Mg2+ in human erythrocytes.
Biochim Biophys Acta 1990; 1035: 169-74.
34 Flatman PW. The effect of buffer composition and
deoxygenation on the concentration of ionized magnesium inside
human red blood cells. J Physiol 1980; 300: 19-30.
35 Günther T, Vormann J, Höllriegl V.
Concentration of intracellular free Mg2+ and
Mg2+ efflux from magnesium-deficient erythrocytes.
Magnes Bull 1990; 12: 43-6.
36 Golding EM, Dobson GP, Golding RM. A critical
assessment of noise-induced errors in 31P MRS:
application to the measurement of free intracellular magnesium in
vivo. MRM 1996; 35: 174-85.
37 Brooks KJ, Bachelard HS. Changes in intracellular
free magnesium during hypoglycaemia and hypoxia in cerebral tissue
as calculated from 31P-nuclear magnetic resonance
spectra. J Neurochem 1989; 53: 331-4.
38 Halvorson HR, Van de Linde AMQ, Helpern JA,
Welch KMA. Assessment of magnesium concentrations by
31P NMR in vivo. NMR Biomed 1992; 5: 53-8.
39 Malloy CR, Cunningham CC, Radda GK. The
metabolic state of the rat liver in vivo measured by
31P-NMR spectroscopy. Biochim Biophys Acta 1986; 885:
1-11.
40 Desmoulin F, Cozzone PJ, Canioni P.
Phosphorus-31 nuclear-magnetic- resonance study of phosphorylated
metabolites compartmentation, intracellular pH and phosphorylation
state during normoxia. hypoxia and ethanol perfusion, in the
perfused rat liver. Eur J Biochem 1987; 162: 151-9.
41 Kushmerick MJ, Dillon PF, Meyer RA,
Brown TR, Krisanda JM, Sweeney HL. 31P
NMR spectroscopy, chemical analysis, and free Mg2+ of
rabbit bladder and uterine smooth muscle. J Biol Chem 1986; 261:
14420-9.
42 Ryschon TW, Rosenstein DL, Rubinow DR,
Niemela JE, Elin RJ, Balaban RS. Relationship
between skeletal muscle intracellular ionized magnesium and
measurements of blood magnesium. J Lab Clin Med 1996; 127:
207-13.
43 Wu ST, Pieper GM, Salhany JM, Eliot RS.
Measurement of free magnesium in perfused and ischemic arrested
heart muscle. A quantitative phosphorus-31 nuclear magnetic
resonance and multiequilibria analysis. Biochemistry 1981; 20:
7399-403.
44 Gupta RK, Moore RD. 31P NMR studies of
intracellular free Mg2+ in intact frog skeletal muscle.
J Biol Chem 1980; 255: 3987-93.
45 Nakayama S, Nomura H, Tomita T. Intracellular
free magnesium in the smooth muscle of guinea pig taenia caeci: a
concomitant analysis for magnesium and pH upon sodium removal. J
Gen Physiol 1994; 103: 833-51.
46 Gupta RK, Yushok WD. Noninvasive 31P NMR
probes of free Mg2+. MgATP, and MgADP in intact Ehrlich
ascites tumor cells. Proc Natl Acad Sci USA 1980; 77: 2487-91.
47 Ware JA, Smith M, Fossel ET, Salzman EW.
Cytoplasmic Mg2+ concentration in platelets:
implications for determination of Ca2+ with aequorin. Am
J Physiol 1988; 255: H855-H859.
48 Rink TJ, Tsien RY, Pozzan T. Cytoplasmic pH
and free Mg2+ in lymphocytes. J Cell Biol 1982; 95:
189-96.
49 Lopez JR, Alamo L, Caputo C, Vergara J,
DiPolo R. Direct measurement of intracellular free magnesium
in frog skeletal muscle using magnesium-selective microelectrodes.
Biochim Biophys Acta 1984; 804: 1-7.
50 Hess P, Metzger P, Weingart R. Free magnesium
in sheep, ferret and frog striated muscle at rest measured with
ion-selective micro-electrodes. J Physiol 1982; 333: 173-88.
51 Günzel D, Galler S. Intracellular free
Mg2+ concentration in skeletal muscle fibres of frog and
crayfish. Pflügers Arch Eur J Physiol 1991; 417: 446-53.
52 MacDermott M. The intracellular concentration of free
magnesium in extensor digitorum longus muscles of the rat. Exp
Physiol 1990; 75: 763-9.
53 Buri A, Chen S, Fry CH, Illner H,
Kickenweiz E, McGuigan JAS, Noble D, Powell T,
Twist VW. The regulation of intracellular Mg2+ in
guinea-pig heart, studied with Mg2+-selective
microelectrodes and fluorochromes. Exp Physiol 1993; 78:
221-33.
54 Buri A, McGuigan JAS. Intracellular free magnesium
and its regulation, studied in isolated ferret ventricular muscle
with ion-selective microelectrodes. Exp Physiol 1990; 75:
751-61.
55 Mooren FC, Turi S, Günzel D, Schlue W-R,
Domschke W, Singh J, Lerch MM. Calcium-magnesium
interactions in pancreatic acinar cells. FASEB J 2001; 15:
659-72.
56 Alvarez-Leefmans FJ, Gamino SM, Rink TJ.
Intracellular free magnesium in neurones of Helix Aspersa measured
with ion-selective micro-electrodes. J Physiol 1984; 354:
303-17.
57 Dai L-J, Quamme GA. Cyclic nucleotides alter
intracellular free Mg2+ in renal epithelial cells. Am J
Physiol 1992; 262: F1100-F1104.
58 Hwang DL, Yen CF, Nadler JL. Insulin increases
intracellular magnesium transport in human platelets. J Clin
Endocrinol Metab 1993; 76: 549-53.
59 Takaya J, Higashino H, Miyazaki R,
Kobayashi Y. Effects of insulin and insulin- like growth
factor-1 on intracellular magnesium of platelets. Exp Mol Pathol
1998; 65: 104-9.
60 Touyz RM, Schiffrin EL. The effect of angiotensin
II on platelet intracellular free magnesium and calcium ionic
concentrations in essential hypertension. J Hypertens 1993; 11:
551-8.
61 Ng LL, Davies JE, Garrido MC. Intracellular
free magnesium in human lymphocytes and the response to lectins.
Clin Sci 1991; 80: 539-47.
62 Ishijima S, Sonoda T, Tatibana M.
Mitogen-induced early increase in cytosolic free Mg2+
concentration in single Swiss 3T3 fibroblasts. Am J Physiol 1991;
261: C1074-C1080.
63 Ishijima S, Tatibana M. Rapid mobilization of
intracellular Mg2+ by bombesin in Swiss 3T3 cells:
Mobilization through external Ca2+- and tyrosine kinase-
dependent mechanisms. J Biochem (Tokyo) 1994; 115: 730-7.
64 Zhang GH, Melvin JE. Secretagogue-induced
mobilization of an intracellular Mg2+ pool in rat
sublingual mucous acini. J Biol Chem 1992; 267: 20721-7.
65 Okada K, Ishikawa S-E, Saito T. Cellular
mechanisms of vasopressin and endothelin to mobilize
[Mg2+]i in vascular smooth muscle cells. Am J
Physiol 1992; 263: C873-C878.
66 Touyz RM, Schiffrin EL. Angiotensin II and
vasopressin modulate intracellular free magnesium in vascular
smooth muscle cells through Na+-dependent protein kinase
C pathways. J Biol Chem 1996; 271: 24353-8.
67 Singh J, Wisdom DM. Second messenger role of
magnesium in pancreatic acinar cells of the rat. Mol Cell Biochem
1995; 149/150: 175-82.
68 Rotevatn S, Sarheim H, Murphy E. Intracellular
free magnesium concentration: relevance to cardiovascular medicine.
Acta Physiol Scan 1991; S599: 125-33.
69 Drakenberg T. Physical methods for studying the
biological chemistry of magnesium. In: Cowan JA, ed. The
Biological Chemistry of Magnesium. New York, Weinheim, Cambridge:
VCH Publishers Inc., 1995: 27.
70 Stauff J, Jaenicke R. Physikalische Chemie der
Lösungen. In: Rauen HM, ed. Biochemisches Taschenbuch,2. Teil,
2. Auflage. Berlin, Göttingen, Heidelberg, New York:
Springer-Verlag, 1964: S.37.
71 Reboiras MD, Pfister H, Pauly H. Activity
coefficients of salts in highly concentrated protein solutions. I.
Alkali chlorides in isoionic bovine serum albumin solutions.
Biophys Chem 1978; 9: 37-46.
72 Altura BM, Altura BT. Role of magnesium in the
pathogenesis of hypertension updated: Relationship to its actions
on cardiac, vascular smooth muscle, and endothelial cells. In:
Laragh JH, Brenner BM, eds. Hypertension:
Pathophysiology, Diagnosis and Management, sec ed. New York: Raven
Press, Ltd, 1995: 1213-42.
73 Quamme GA, Dai L-J, Rabkin SW. Dynamics of
intracellular free Mg2+ changes in a vascular smooth
muscle cell line. Am J Physiol 1993; 265: H281-H288.
74 Sébille S, Millot JM, Maizières M,
Arnaud M, Delabroise AM, Jacquot J, Manfait M.
Spatial and temporal Mg2+ signaling in single human
tracheal gland cells. Biochem Biophys Res Commun 1996; 227:
743-9.
75 Han JW, Thieleczek R, Varsanyi M,
Heilmeyer Jr. LMG. Compartmentalized ATP synthesis in
skeletal muscle triads. Biochemistry 1992; 31: 377-84.
76 Xu KY, Zweier JL, Becker LC. Functional
coupling between glycolysis and sarcoplasmic reticulum
Ca2+ transport. Circ Res 1995; 77: 88-97.
77 Agus ZS, Morad M. Modulation of cardiac ion
channels by magnesium. Annu Rev Physiol 1991; 53: 299-307.
78 Gwanyanya A, Amuzescu B, Zakharov SI,
Macianskiene R, Sipido KR, Bolotina VM,
Vereecke J, Mubagwa K. Magnesium-inhibited, TRPM6/7-like
channel in cardiac myocytes: permeation of divalent cations and
pH-mediated regulation. J Physiol 2004; 559: 761-76.
79 Fleig A, Penner R. The TRPM ion channel subfamily:
molecular, biophysical and functional features. Trends Pharmacol
Sci 2004; 25: 633-9.
80 Günther T. Beiträge zur biologischen Bedeutung des
Magnesiums. Habilitationsschrift FU Berlin, 1965.
81 Garner PS, Rosett T. The influence of
Mg2+/adenine nucleotide ratios and absolute
concentration of Mg2+/adenine nucleotide on the observed
velocity of some kinase reactions. FEBS Lett 1973; 34: 243-6.
82 Iyengar R, Birnbaumer L. Hormone receptor modulates
the regulatory component of adenylyl cyclase by reducing its
requirement for Mg2+ and enhancing its extent of
activation by guanine nucleotides. Proc Natl Acad Sci USA 1982; 79:
5179-83.
83 Günther T. Über die Rolle des Mg bei der Regulation des
Zellstoffwechsels. Z Naturforsch 1966; 21b: 1174-7.
84 Laughlin MR, Thompson D. The regulatory role for
magnesium in glycolytic flux of the human erythrocyte. J Biol Chem
1996; 271: 28977-83.
85 Günther T, Vormann J, Förster R. Functional
compartmentation of intracellular magnesium. Magnes Bull 1984; 6:
77-81.
86 Panov A, Scarpa A. Mg2+ control of
respiration in isolated rat liver mitochondria. Biochemistry 1996;
35: 12849-56.
87 Rodriguez-Zavala JS, Moreno-Sanchez R. Modulation
of oxidative phosphorylation by Mg2+ in rat heart
mitochondria. J Biol Chem 1998; 273: 7850-5.
88 Vernon WB. The role of magnesium in nucleic-acid and
protein metabolism. Magnesium 1988; 7: 234-48.
89 Garfinkel D, Garfinkel L. Magnesium and regulation
of carbohydrate metabolism at the molecular level. Magnesium 1988;
7: 249-61.
90 Grubbs RD, Maguire ME. Magnesium as a regulatory
cation: criteria and evaluation. Magnesium 1987; 6: 113-27.
91 Takaya J, Higashino H, Kobayashi Y. Can
magnesium act as a second messenger? Current data on translocation
induced by various biologically active substances. Magnes Res 2000;
13: 139-46.
92 Rubin H. The membrane, magnesium, mitosis (MMM) model of
cell proliferation control. Magnes Res 2005; 18: 268-74.
93 Cameron IL, Smith NKR. Cellular concentration of
magnesium and other ions in relation to protein synthesis, cell
proliferation and cancer. Magnesium 1989; 8: 31-44.
94 Di Francesco A, Desnoyer RW, Covacci V,
Wolf FI, Romani A, Cittadini A, Bond M. Changes
in magnesium content and subcellular distribution during retinoic
acid-induced differentiation of HL 60 cells. Arch Biochem Biophys
1998; 360: 149-57.
95 Wolf FI, Covacci V, Bruzzese N, Di
Francesco A, Sacchetti A, Corda D, Cittadini A.
Differentiation of HL-60 promyelocytic leukemia cells is
accompanied by a modification of magnesium homeostasis. J Cell
Biochem 1998; 71: 441-8.
96 Matsuno K, Koyama M, Takeda H, Abe K,
Sakurada K, Miyazaki T, Kobayashi K. Cytosolic free
magnesium concentration in human platelets. Thromb Res 1993; 69:
131-7.
97 Grubbs RD. Effect of epidermal growth factor on
magnesium homeostasis in BC3H1 myocytes. Am J Physiol
1991; 260: C1158-C1164.
98 Dolmetsch RE, Lewis RS, Goodnow CC,
Healy JI. Differential activation of transcription factors
induced by Ca2+ response amplitude and duration. Nature
1997; 386: 855-8.
99 Carafoli E. Calcium - a universal carrier of biological
signals. FEBS J 2005; 272: 1073-89.
100 Freudenrich CC, Murphy E, Liu S,
Lieberman M. Magnesium homeostasis in cardiac cells. Mol Cell
Biochem 1992; 114: 97-103.
101 Murphy E. Mysteries of magnesium homeostasis. Circ Res
2000; 86: 245-8.
102 Rijkers GT, Griffioen AW. Changes in free
cytoplasmic magnesium following activation of human lymphocytes.
Biochem J 1993; 289: 373-7.
103 Günther T, Vormann J. Intracellular
Ca2+-Mg2+ interactions. Ren Physiol 1994; 17:
279-86.
104 Günther T. Phylogenesis and ontogenesis of magnesium.
Magnes Bull 1994; 16: 143-6.
|